News
With Par Pharmaceutical Suit, Courts Should Put an End to FDA's Lawless Behavior on Off-Label Speech
According to Par, FDA claims that even truthful promotional speech about Megace’s on-label uses is illegal, if directed to doctors which Par knows are highly likely to prescribe Megace for off ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback